These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11339427)

  • 1. A phase one study of the hepatic arterial administration of 1,25-dihydroxyvitamin D3 for liver cancers.
    Finlay IG; Stewart GJ; Ahkter J; Morris DL
    J Gastroenterol Hepatol; 2001 Mar; 16(3):333-7. PubMed ID: 11339427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic arterial and intravenous administration of 1,25-dihydroxyvitamin D3--evidence of a clinically significant hepatic first-pass effect.
    Finlay IG; Stewart GJ; Shirley P; Woolfe S; Pourgholami MH; Morris DL
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):209-14. PubMed ID: 11592342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic intra-arterial injection of 1,25-dihydroxyvitamin D3 in lipiodol: Pilot study in patients with hepatocellular carcinoma.
    Morris DL; Jourdan JL; Finlay I; Gruenberger T; The MP; Pourgholami MH
    Int J Oncol; 2002 Oct; 21(4):901-6. PubMed ID: 12239633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24,25-dihydroxyvitamin D3 in combination with 1,25-dihydroxyvitamin D3 ameliorates renal osteodystrophy in rats with chronic renal failure.
    Gal-Moscovici A; Rubinger D; Popovtzer MM
    Clin Nephrol; 2000 May; 53(5):362-71. PubMed ID: 11305809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
    Koeffler HP; Hirji K; Itri L
    Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
    Hostutler RA; DiBartola SP; Chew DJ; Nagode LA; Schenck PA; Rajala-Schultz PJ; Drost WT
    J Vet Intern Med; 2006; 20(6):1307-13. PubMed ID: 17186842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: response to calcium, vitamin D3 and calcitriol administration in vivo.
    Lemay J; Demers C; Hendy GN; Delvin EE; Gascon-Barré M
    J Bone Miner Res; 1995 Aug; 10(8):1148-57. PubMed ID: 8585417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic expression of regeneration marker genes following partial hepatectomy in the rat. Influence of 1,25-dihydroxyvitamin D3 in hypocalcemia.
    Goupil D; Ethier C; Zarnegar R; Gascon-Barré M
    J Hepatol; 1997 Mar; 26(3):659-68. PubMed ID: 9075675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
    Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3.
    Pourgholami MH; Akhter J; Lu Y; Morris DL
    Cancer Lett; 2000 Apr; 151(1):97-102. PubMed ID: 10766428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe secondary hyperparathyroidism with administration of calcium carbonate, intermittent high oral doses of 1,25-dihydroxyvitamin D3 and dialysate with 3 mEq/1 calcium concentration.
    Perez-Mijares R; Gomez-Fernandez P; Almaraz-Jimenez M; Ramos-Diaz M; Rivero-Bohorquez J
    Am J Nephrol; 1993; 13(2):149-54. PubMed ID: 8342582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental salinity regulates the in vitro production of [3H]-1,25-dihydroxyvitamin D3 and [3H]-24,25 dihydroxyvitamin D3 in rainbow trout (Oncorhynchus mykiss).
    Sundh H; Larsson D; Sundell K
    Gen Comp Endocrinol; 2007; 152(2-3):252-8. PubMed ID: 17292365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic intra-arterial injection of lipiodol-1,25-dihydroxyvitamin D3 for hepatocellular carcinoma in rats.
    Jourdan JL; Akhter J; Bowrey P; Pourgholami M; Morris DL
    Anticancer Res; 2000; 20(4):2739-44. PubMed ID: 10953352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate.
    Halloran BP; Bikle DD; Levens MJ; Castro ME; Globus RK; Holton E
    J Clin Invest; 1986 Sep; 78(3):622-8. PubMed ID: 3489007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined supplementation of vanadium and 1alpha,25-dihydroxyvitamin D3 inhibit placental glutathione S-transferase positive foci in rat liver carcinogenesis.
    Basak R; Chatterjee M
    Life Sci; 2000 Dec; 68(2):217-31. PubMed ID: 11191639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elongation of the side chain of analogs of 1 alpha,25-dihydroxyvitamin D3 prevents osteopenia in a rat model.
    Harada M; Takamura T; Kajita-Kondo S; Kozakai A; Miyahara T; Kozuka H; Ikekawa N; Higuchi S; Otomo S
    Calcif Tissue Int; 1995 Mar; 56(3):220-6. PubMed ID: 7750028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of lipiodol and medium chain triglyceride as delivery agents for hepatic arterial administration of 1, 25-dihydroxyvitamin D3--a potential new treatment for hepatocellular carcinoma.
    Finlay IG; Stewart GJ; Pourgholami MH; Akhter J; Morris DL
    Anticancer Res; 2000; 20(4):2705-9. PubMed ID: 10953347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.